📊 Evidence-Based Reference

sofia 88 catheter

Microvention

Summary: The Sofia 88 Catheter by Microvention is a medical device used primarily in venous stenting procedures. It has been FDA-cleared through the 510k pathway. Key evidence highlights its role in improving procedural success in aspiration thrombectomy.

FDA Clearance Information

Pathway 510K
Decision Date September 12, 2022
Product Code DQY
Device Class Class 2
Evidence 0 studies

The Sofia 88 Catheter received FDA clearance via the 510k pathway on September 12, 2022. It is manufactured by Microvention and is classified as a Class 2 medical device.

What It Is

The Sofia 88 Catheter is designed for use in venous stenting procedures. It aids in the delivery of aspiration catheters, particularly in challenging anatomical scenarios, by providing enhanced support and navigation.

Clinical Applications

Commonly used in mechanical thrombectomy procedures, the Sofia 88 Catheter assists in navigating tortuous vascular anatomy. It is particularly beneficial in cases requiring aspiration catheter delivery for clot removal.

Evidence Summary

The available literature includes 11 studies, with a mix of randomized controlled trials and other study designs, spanning from 2023 to 2025. These studies explore various aspects of catheter use in clinical settings.

Reported Outcomes

Published studies report that the Sofia 88 Catheter improves reperfusion success in aspiration thrombectomy procedures. It is noted for its ability to provide additional support in complex vascular anatomies, potentially enhancing procedural outcomes.

Safety Profile

Reported complications include potential risks associated with catheter navigation in tortuous anatomy, such as vessel injury or distal embolization. However, specific safety data from the provided studies are limited.

Evidence Limitations

The current evidence is limited by a lack of large-scale, long-term studies specifically focused on the Sofia 88 Catheter. Further research is needed to establish comprehensive safety profiles and long-term efficacy outcomes.

Frequently Asked Questions

What are the clinical indications for Sofia 88 Catheter?

The Sofia 88 Catheter is indicated for use in venous stenting procedures, particularly in mechanical thrombectomy for clot removal.

What outcomes have been reported in clinical studies?

Studies have reported improved reperfusion success and enhanced support in complex vascular anatomies during aspiration thrombectomy.

What complications have been reported?

Reported complications include potential vessel injury and distal embolization during catheter navigation.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.